FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3142287129> ?p ?o ?g. }

• W3142287129 abstract "Abstract Background: There is no clinical study investigating if using CAZ-AVI combination schemes with an in vitro non-susceptible antimicrobial could be superior to CAZ-AVI monotherapy against CRKP clinically. Methods: We performed a retrospective, cohort study at two tertiary hospitals in China for patients with CRKP infection who treated by CAZ-AVI at least 72 hours. A Cox-proportional hazards regression model was set up to evaluate covariates which potentially affected 30-day mortality. Results: Sixty-two patients were eligible in our study, 41 (66.1%) received CZA-AVI combination therapy and 21 (33.9%) received CZA-AVI monotherapy. The overall 30-day mortality was 33.9% (21 patients): 24.4% (10/41) and 47.6% (11/21), P =0.028, in combination and monotherapy groups, respectively. Combination therapy was significantly associated with lower 30-day mortality (HR 0.167, 95%CI 0.060-0.465, P =0.001), while higher APACHE II score, use of vasoactive drug and comorbidity of organ transplantation were considered as factors on increasing mortality. The propensity score showed no significant alteration with other variables after adding it into the final model. In the subgroup analysis, the protective effect revealed when combination with carbapenems, tigecycline or fosfomycin were applied, and in the following subgroups of patients: with sepsis, with CrCl > 50 mL/min, stayed in ICU ≤30 days or underwent mechanical ventilation. Conclusions: CAZ-AVI combination with another in vitro non-susceptible antimicrobial, especially carbapenems, fosfomycin and tigecycline, could significantly decrease 30-day mortality rate for critically ill patients with CRKP infection. Further investigation should be carried out to confirm this conclusion and find out the autofit antimicrobials in CAZ-AVI combination schemes." @default.
• W3142287129 created "2021-04-13" @default.
• W3142287129 creator A5023492006 @default.
• W3142287129 creator A5039841390 @default.
• W3142287129 creator A5057361144 @default.
• W3142287129 creator A5059602238 @default.
• W3142287129 creator A5060965556 @default.
• W3142287129 creator A5067119226 @default.
• W3142287129 creator A5070112937 @default.
• W3142287129 creator A5078938441 @default.
• W3142287129 creator A5081686849 @default.
• W3142287129 creator A5084108078 @default.
• W3142287129 creator A5086915413 @default.
• W3142287129 date "2021-04-03" @default.
• W3142287129 modified "2023-09-23" @default.
• W3142287129 title "Ceftazidime-avibactam in combination with in vitro non-susceptible antimicrobials versus ceftazidime-avibactam in monotherapy in critically ill patients with carbapenem-resistant Klebsiella pneumoniae infection" @default.
• W3142287129 doi "https://doi.org/10.21203/rs.3.rs-371308/v1" @default.
• W3142287129 hasPublicationYear "2021" @default.
• W3142287129 type Work @default.
• W3142287129 sameAs 3142287129 @default.
• W3142287129 citedByCount "0" @default.
• W3142287129 crossrefType "posted-content" @default.
• W3142287129 hasAuthorship W3142287129A5023492006 @default.
• W3142287129 hasAuthorship W3142287129A5039841390 @default.
• W3142287129 hasAuthorship W3142287129A5057361144 @default.
• W3142287129 hasAuthorship W3142287129A5059602238 @default.
• W3142287129 hasAuthorship W3142287129A5060965556 @default.
• W3142287129 hasAuthorship W3142287129A5067119226 @default.
• W3142287129 hasAuthorship W3142287129A5070112937 @default.
• W3142287129 hasAuthorship W3142287129A5078938441 @default.
• W3142287129 hasAuthorship W3142287129A5081686849 @default.
• W3142287129 hasAuthorship W3142287129A5084108078 @default.
• W3142287129 hasAuthorship W3142287129A5086915413 @default.
• W3142287129 hasBestOaLocation W31422871291 @default.
• W3142287129 hasConcept C104317684 @default.
• W3142287129 hasConcept C126322002 @default.
• W3142287129 hasConcept C167135981 @default.
• W3142287129 hasConcept C207103383 @default.
• W3142287129 hasConcept C2775933652 @default.
• W3142287129 hasConcept C2776685102 @default.
• W3142287129 hasConcept C2776968632 @default.
• W3142287129 hasConcept C2776999253 @default.
• W3142287129 hasConcept C2777027569 @default.
• W3142287129 hasConcept C2777058267 @default.
• W3142287129 hasConcept C2777406300 @default.
• W3142287129 hasConcept C2777637488 @default.
• W3142287129 hasConcept C2778897966 @default.
• W3142287129 hasConcept C2779259085 @default.
• W3142287129 hasConcept C2779375183 @default.
• W3142287129 hasConcept C44249647 @default.
• W3142287129 hasConcept C4937899 @default.
• W3142287129 hasConcept C501593827 @default.
• W3142287129 hasConcept C523546767 @default.
• W3142287129 hasConcept C54355233 @default.
• W3142287129 hasConcept C547475151 @default.
• W3142287129 hasConcept C55493867 @default.
• W3142287129 hasConcept C71924100 @default.
• W3142287129 hasConcept C86803240 @default.
• W3142287129 hasConcept C89423630 @default.
• W3142287129 hasConcept C94665300 @default.
• W3142287129 hasConceptScore W3142287129C104317684 @default.
• W3142287129 hasConceptScore W3142287129C126322002 @default.
• W3142287129 hasConceptScore W3142287129C167135981 @default.
• W3142287129 hasConceptScore W3142287129C207103383 @default.
• W3142287129 hasConceptScore W3142287129C2775933652 @default.
• W3142287129 hasConceptScore W3142287129C2776685102 @default.
• W3142287129 hasConceptScore W3142287129C2776968632 @default.
• W3142287129 hasConceptScore W3142287129C2776999253 @default.
• W3142287129 hasConceptScore W3142287129C2777027569 @default.
• W3142287129 hasConceptScore W3142287129C2777058267 @default.
• W3142287129 hasConceptScore W3142287129C2777406300 @default.
• W3142287129 hasConceptScore W3142287129C2777637488 @default.
• W3142287129 hasConceptScore W3142287129C2778897966 @default.
• W3142287129 hasConceptScore W3142287129C2779259085 @default.
• W3142287129 hasConceptScore W3142287129C2779375183 @default.
• W3142287129 hasConceptScore W3142287129C44249647 @default.
• W3142287129 hasConceptScore W3142287129C4937899 @default.
• W3142287129 hasConceptScore W3142287129C501593827 @default.
• W3142287129 hasConceptScore W3142287129C523546767 @default.
• W3142287129 hasConceptScore W3142287129C54355233 @default.
• W3142287129 hasConceptScore W3142287129C547475151 @default.
• W3142287129 hasConceptScore W3142287129C55493867 @default.
• W3142287129 hasConceptScore W3142287129C71924100 @default.
• W3142287129 hasConceptScore W3142287129C86803240 @default.
• W3142287129 hasConceptScore W3142287129C89423630 @default.
• W3142287129 hasConceptScore W3142287129C94665300 @default.
• W3142287129 hasLocation W31422871291 @default.
• W3142287129 hasOpenAccess W3142287129 @default.
• W3142287129 hasPrimaryLocation W31422871291 @default.
• W3142287129 hasRelatedWork W2167256781 @default.
• W3142287129 hasRelatedWork W2982773974 @default.
• W3142287129 hasRelatedWork W2986528364 @default.
• W3142287129 hasRelatedWork W2990287059 @default.
• W3142287129 hasRelatedWork W3095228502 @default.
• W3142287129 hasRelatedWork W3126945909 @default.
• W3142287129 hasRelatedWork W3127753055 @default.
• W3142287129 hasRelatedWork W3195214966 @default.
• W3142287129 hasRelatedWork W3197143332 @default.
• W3142287129 hasRelatedWork W4366609072 @default.
• W3142287129 isParatext "false" @default.

• next